Bullish and bearish reversals for this week.
Akari Therapeutics, Array BioPharma and Amicus Therapeutics were among the biotech movers in premarket trading on Wednesday.
Arrary reacquired MEK inhibitor in 2015 as part of FTC settlement with Novartis.
Here's what traders are saying.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.